XML 66 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Details Narrative)
12 Months Ended
Dec. 31, 2024
USD ($)
Segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Product Information [Line Items]      
Restricted cash $ 10,239,000 $ 9,936,000  
Accounts receivable balance, net of allowance for credit losses 13,357,000 10,046,000 $ 4,452,000
Indefinite-lived IPR&D 107,800,000  
Number of operating segments | Segment 3    
Advertising and marketing costs $ 23,000 44,000  
Grant monies 0 0  
Instrument-specific credit risk loss $ 5,000    
Instrument-specific credit risk income   146,000  
Accumulated other comprehensive income   $ 155,000  
Income tax examination likelihood settlement The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]      
Product Information [Line Items]      
Concentration risk, percentage 46.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]      
Product Information [Line Items]      
Concentration risk, percentage   41.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]      
Product Information [Line Items]      
Concentration risk, percentage 17.00% 14.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]      
Product Information [Line Items]      
Concentration risk, percentage 16.00% 13.00%  
Minimum [Member]      
Product Information [Line Items]      
Contracted storage periods 18 years    
Over time for a period 1 month    
Maximum [Member]      
Product Information [Line Items]      
Contracted storage periods 25 years    
Over time for a period 24 months    
Cell Therapy [Member]      
Product Information [Line Items]      
Goodwill impairment $ 0 $ 112,347,000  
Letter of Credit [Member]      
Product Information [Line Items]      
Restricted cash $ 10,239,000 $ 9,936,000